Lv4
740 积分 2023-05-04 加入
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients
2个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
2个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
4个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
5个月前
已完结
Plasma proteomic profiles predict future dementia in healthy adults
5个月前
已完结
Divergent biological pathways linking short and long sleep durations to mental and physical health
5个月前
已完结
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
5个月前
已完结
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
11个月前
已完结
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases
1年前
已完结
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy
1年前
已完结
皖公网安备34019202002308
